J Liver Cancer Search

CLOSE


J Liver Cancer > Volume 15(2); 2015 > Article
Journal of Liver Cancer 2015;15(2):84-97.
DOI: https://doi.org/10.17998/jlc.15.2.84    Published online September 30, 2015.
An A to Z of Lipiodol Beyond the Clinical Practice in the Management of Hepatocellular Carcinoma
Eileen L. Yoon
Division of Gastroenterology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea
Correspondence:  Eileen L. Yoon,
Email: mseileen80@naver.com
Copyright ©2015 by The Korean Liver Cancer Association
Abstract
Lipiodol based conventional transarterial chemoembolization (TACE) is a standard of care for unresectable, non-invasive, and multinodular Hepatocellular carcinoma (HCC)s. The procedure relies on the intra-arterial administration of lipiodol/cytotoxic agent emulsion followed by the infusion of embolic material. Lipiodol, with its oily nature and radiopacifying properties, is in the center of the TACE procedure. Unstability and unpredictable therapeutic effect of hydrophilic cytotoxic drugs emulsified in the lipiodol and technical problems lie beyond the control of clinicians. Thus, interest in the properties and respective roles for lipiodol in the management of HCC is essential for the clinicians. (J Liver Cancer 2015;15:84-87)
Key Words: Lipiodol; Hepatocellular carcinoma; Transarterial chemoembolization
NULL


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
1527 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2019 by The Korean Liver Cancer Association. All rights reserved.

Developed in M2community

Close layer
prev next